Table 2.
Control(n=80) | Patients with AS (n=80) | Patients with RA (n=80) | p1 | p2 | p3 | p4 | |
---|---|---|---|---|---|---|---|
PCTF(mean ± SD) | 19.4 ± 5.6 | 20.5 ± 7.1 | 19.2 ± 6.5 | 0.429 | 0.284 | 0.908 | 0.242 |
PGWB(mean ± SD) | 45.7 ± 6.9 | 42.6 ± 10.0 | 42.1 ± 10.1 | 0.024 * | 0.024 * | 0.014 * | 0.819 |
SIS(median [min-max]) | 1 (0–11) | 2 (0–14) | 2 (0–15) | 0.215 | 0.141 | 0.118 | 0.881 |
PACT(mean ± SD) | 100.7 ± 14.4 | 96.5 ± 16.9 | 92.5 ± 17.5 | 0.008 * | 0.105 | 0.002 * | 0.131 |
PACT trauma-focused coping(mean ± SD) | 63.8 ± 13.1 | 60.7 ± 14.5 | 59.7 ± 14.7 | 0.160 | 0.168 | 0.067 | 0.636 |
PACT perceived forward-focused(mean ± SD) | 36.8 ± 7.1 | 35.7 ± 8.9 | 32.9 ± 10.5 | 0.020 * | 0.439 | 0.007 * | 0.050 * |
HADS depression (mean ± SD) | 5.0 ± 3.7 | 7.1 ± 4.7 | 7.2 ± 4 | 0.001 * | 0.002 * | 0.001 * | 0.873 |
HADS Anxiety (mean ± SD) | 6.1 ± 3.7 | 7.5 ± 4.4 | 7.8 ± 5.2 | 0.044 * | 0.019 * | 0.054 | 0.679 |
p1 p value of One way ANOVA or Kruskal–Wallis Test.p2 Healthy controls vs. patients with Ankylosing Spondylitis.p3 Healthy controls vs. patients with Rheumatoid Arthritis.p4 patients with Ankylosing Spondylitis vs. patients with